FCF Biotech
Public Equity Monitor
The Biotech Public Equity Monitor is the most detailed and comprehensive valuation analysis for biotechnology and pharmaceutical companies in the micro, small and midcap market segment in Europe. Categorized by subsectors / indications, it provides relevant valuation metrics (e.g. ratios, multiples), general information, performance data, analyst consensus and shareholder analysis as well as statistics by region and subsector / indication.
FCF Biotech Public Equity Monitor
Share Price Potential...
Performance and Valuation..
Break-Even Analysis...
Liquidity Analysis...
Shareholder Analysis...

As of the end of November 2021, we identify the following trends in Europe:

  • The overall price development of the European therapeutics sector rose by an average of +20% last year
  • Within the Therapeutics Sector, the Infectious Diseases sector recorded the highest share price performance within the last year with +125%, followed by Ophthalmology (+109%) and Respiratory (+52%)
  • Analysts see an average upside potential of +130% in the share prices of the European Therapeutics Sector
FCF Biotech Public Equity Monitor
Share Price Potential...
Performance and Valuation..
Break-Even Analysis...
Liquidity Analysis...
Shareholder Analysis...
To receive a copy please click here

Capital Markets Research

Monthly Venture capital activities in the European Life Sciences sector
Click Here
Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the US Life Sciences sector
Click here
Healthcare & Life Sciences Venture Capital Monitor – USA
Monthly Venture capital activities in the European Life Sciences sector
Click Here
Healthcare & Life Sciences Venture Capital Monitor – Europe
Recent valuations of listed US Life Sciences companies
Click here
Healthcare & Life Sciences Venture Capital Monitor – USA

Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector

Healthcare & Life Sciences Venture Capital Monitor – USA
Monthly Venture capital activities in the US Life Sciences sector

NEWS

more...